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This is an open access article under the CC BY license (http://creativecommNeonatal EEG monitoring in pre-term and full-term infants
offers a window onto neurological functioning, and clinically rele-
vant insights into normative and aberrant development of cortical
activity patterns (Whitehead et al., 2017). We have recently shown
the importance of full 10/20 electrode coverage in neonatal EEG
recordings, due to the prevalence of cortical bursting over the pos-
terior temporal regions (electrodes T6/T5) (Whitehead et al., 2017).
Nevertheless, 10/20 EEG application involves a relatively high level
of handling and could be a potential stressor, especially in those
infants who are already exhibiting higher stress levels.
Salivary cortisol reflects activity of the hypothalamic pituitary
axis: increased cortisol concentration indicates increased stress.
To assess the impact of EEG set-up on systemic stress levels in hos-
pitalised infants, we measured salivary cortisol immediately before
EEG application, and approximately 15 min after the completion of
EEG application (median time between swabs: 46 min), based on
the latency and duration of stressor-induced changes in cortisol
concentration in infants (Ramsay and Lewis, 2003). EEG applica-
tion occurred between 09:00 and 17:30. Subjects included 33
un-sedated infants with gestational age 26 + 4–41 + 6 weeks +
days (median 36 + 4), corrected age 32 + 3–47 + 6 weeks + days
(median 37 + 5), and postnatal age 0.5–95 days (median 5 days).
Ethical approval was obtained from the NHS Health Research
Authority and informed written parental consent was obtained
prior to each study. Separate written consent was obtained to pub-
lish a photograph of an infant having electrodes placed.
Disposable Ag/AgCl cup electrodes were applied by an experi-
enced clinical scientist (KW). The median number of electrodes
applied was 18 (maximum 19), in addition to the ground and ref-
erence, single lead ECG and a respiratory monitor. Target impe-
dance was <10 kX. All infants were offered individualised,
developmentally appropriate comfort measures during EEG appli-
cation as and when required (e.g. swaddling if they became unset-
tled). Saliva samples were collected pre- and post-EEG application
by a research nurse (PLD) using a cotton swab. The swabs were
then frozen at 20 C until ready for analysis. Samples were
assayed in duplicate when possible at a Salimetrics lab, using an
enzyme immunoassay that has a lower limit of sensitivity of
0.007 mg/dL and a standard curve range from 0.012 to 3.0 mg/dL.
The average intra- and inter-assay coefficients of variation were
low (3.4% and 7.6%, respectively). Cortisol concentration pre- and
post-EEG application was compared with paired Wilcoxon tests
because they were not normally distributed (Shapiro-Wilk test).
Unpaired variables were compared with Mann-Whitney or chi-
squared tests. Data analysis was carried out using IBM SPSS version
22. Statistical significance was set at 0.05.Published by E
ons.org/licenseMedian cortisol concentration pre-EEG application was 0.27 mg/
dL (range 0.09–2.91), and post-EEG application was 0.37 mg/dL
(range 0.03–1.74), values similar to those found in previous neona-
tal studies (Mörelius et al. 2016). There was no difference between
cortisol concentration pre- and post-EEG application across the 33
infants (p = .201). In particular, this was also the case for vulnera-
ble sub-groups (corrected age: pre-term (<37 weeks), n = 13; ward
location: special care or high dependency unit, n = 14) (p  0.432).
Next, we investigated whether baseline stress level influenced
the effect of EEG application by splitting infants into those with
higher pre-EEG cortisol concentration (0.25 mg/dL, n = 17) and
lower pre-EEG cortisol concentration (<0.25 mg/dL, n = 16). Infants
with a higher pre-EEG cortisol value had a higher corrected age
than infants with a lower pre-EEG cortisol value (p = .017), while
there was no difference in sex distribution (p = .881), ward location
(special care or high dependency unit vs. postnatal ward, p = .881),
or mode of delivery (vaginal vs. caesarean section, p = .866). EEG
application was associated with a decrease in cortisol concentra-
tion in infants who had a higher concentration at baseline (p =
.023; median 0.31 mg/dL decrease, which is a median 41% decrease
in the pre-EEG value), and no change in infants who had a lower
cortisol concentration at baseline (p = .120) (Fig. 1).
Stress in hospitalised neonates is associated with adverse clin-
ical signs, including increased nociceptive cortical response follow-
ing a necessary heel lance, and fluctuations in intracranial blood
pressure (Jones et al., 2017; Mörelius et al., 2016). Consequently,
it is important to assess the impact of interventions, like EEG appli-
cation, on systemic stress levels. In this study we have shown that
EEG application, alongside appropriate comfort measures, does not
necessarily increase stress levels in hospitalised infants. Our
results should be interpreted conservatively because the hospital
environment and cumulative exposure to stressful procedures
could mask or alter reactivity. Nevertheless, previous studies have
demonstrated that salivary cortisol can significantly increase in
hospitalised neonates following a non-invasive stressor lasting
approximately as long as EEG application (neurological examina-
tion) (Mörelius et al., 2016). Therefore our finding that EEG appli-
cation is not associated with an increase in stress levels is
reassuring and supports our clinical impression (based on beha-
vioural observation, and review of heart rate and pulse oximetry
acquired by cot-side monitors where available) that EEG applica-
tion can be well tolerated by both pre-term and full-term infants.
Interestingly we show that EEG application is actually associ-
ated with decreased stress levels in infants with higher stress levels
at baseline. In line with this EEG-associated decrease in cortisol
levels, tactile stimulation of the head and body decreases stress
behaviours in neonates (Hernandez-Reif et al., 2007). Further, gen-
tle time-limited sensory stimulation significantly reduces salivary
cortisol concentration in neonates (music: Schwilling et al., 2015)
and older infants (swimming; riding in car, irrespective of whetherlsevier B.V.
s/by/4.0/).
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Fig. 1. EEG application is not associated with any change in cortisol concentration in infants with a lower stress level at baseline, while it is associated with a decrease in
cortisol concentration in infants with a higher stress level at baseline. Each coloured line represents one infant.
Letter to the Editor / Clinical Neurophysiology Practice 3 (2018) 20–21 21sleep occurs: reviewed in Jansen et al. 2010). Therefore it is possi-
ble that EEG application has the potential to be soothing when car-
ried out by experienced staff, especially in conjunction with
comfort measures as necessary, which neonates with higher stress
levels may be more likely to both require and benefit from.
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